0001958244-23-002830.txt : 20231215
0001958244-23-002830.hdr.sgml : 20231215
20231215172426
ACCESSION NUMBER: 0001958244-23-002830
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: 4D Molecular Therapeutics, Inc.
CENTRAL INDEX KEY: 0001650648
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473506994
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39782
FILM NUMBER: 231491442
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5105052680
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc.
DATE OF NAME CHANGE: 20200506
FORMER COMPANY:
FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc
DATE OF NAME CHANGE: 20150811
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kirn David
CENTRAL INDEX KEY: 0001834021
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O 4D MOLECULAR THERAPEUTICS INC.
STREET 2: 5858 HORTON STREET #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
144
1
primary_doc.xml
144
0001834021
XXXXXXXX
LIVE
0001650648
4D Molecular Therapeutics, Inc.
001-39782
5858 Horton Street
Suite 455
Emeryville
CA
94608
1-510-505-2680
David Kirn
Officer
Class A Common Shares
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
28632
508504.32
42753607
12/15/2023
NASD
Class A Common Shares
12/15/2020
Founder's Shares
Issuer
N
28632
12/15/2020
None
Y
The sales of shares set forth herein are made in connection with a selling plan dated 8/17/2023 that is intended to comply with Rule 10b5-1(c).
12/15/2023
08/17/2023
Goldman Sachs & Co. LLC on behalf of David Kirn